ARMISTICE CAPITAL, LLC - 30 Sep 2025 SCHEDULE 13G Report for CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value
Symbol: CTOR
Shares outstanding: 78,405,628 shares
Disclosed Ownership: 7,675,911 shares
Ownership: 9.8%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 18:41:22 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.8%	7,675,911	0	7,675,911	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.8%	7,675,911	0	7,675,911	/s/ Steven Boyd	Steven Boyd